Transformed follicular lymphoma (tFL): consolidation therapy may improve survival.

about

Transformed follicular lymphoma (tFL): consolidation therapy may improve survival.

Item

http://www.wikidata.org/entity/Q38891949

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Transformed follicular lymphoma (tFL): consolidation therapy may improve survival.

@en

type

Item

label

Transformed follicular lymphoma (tFL): consolidation therapy may improve survival.

@en

prefLabel

Transformed follicular lymphoma (tFL): consolidation therapy may improve survival.

@en

P1476

Transformed follicular lymphoma (tFL): consolidation therapy may improve survival.

@en

P2093

E Conneally

http://www.w3.org/2001/XMLSchema#string

E Elhassadi

http://www.w3.org/2001/XMLSchema#string

E Higgins

http://www.w3.org/2001/XMLSchema#string

P Browne

http://www.w3.org/2001/XMLSchema#string

P Hayden

http://www.w3.org/2001/XMLSchema#string

P2860

Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma.

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource.

High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study.

Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma.

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

P2888

s11845-017-1594-z

P31

scholarly article

P356

10.1007/S11845-017-1594-Z

http://www.w3.org/2001/XMLSchema#string

P50

Elisabeth Vandenberghe

Richard Flavin

Fiona M Quinn

P577

2017-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084504678

http://www.w3.org/2001/XMLSchema#string

P698

28321641

http://www.w3.org/2001/XMLSchema#string